Platelet activity is enhanced in patients with DM due to several mechanisms [33, 34], which also include upregulation of Nox2: This has been previously described in patients with DM and linked with an increased risk of cardiovascular events in these subjects [35, 36]. Here, CYBB is linked to diabetes mellitus.